Serial Echocardiography in Pediatric Pulmonary Arterial Hypertension: A Narrative Review
Diagnostics · 16.11.2026 · 16 (22) · 3802
DOI: 10.3390/diagnostics16223802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.11.2026. Verfasst von Cosmin Diaconescu und 8 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Echocardiography is central to the serial evaluation of children with pulmonary arterial hypertension (PAH), but the evidence supporting each measurement addresses distinct questions: measurement reliability, association with invasive hemodynamics, prediction of clinical events, and change during treatment. Rather than cataloguing imaging techniques, this focused narrative review provides a domain-by-domain evidence map and a practical interpretation framework for follow-up. PubMed-based targeted literature retrieval and citation tracing were used to assemble pediatric reference, method-comparison, hemodynamic validation, prognostic, and longitudinal studies; formal systematic screening or certainty grading was not performed. Evidence is explicitly stratified by PAH-specific versus broader pulmonary hypertension (PH) populations. Tricuspid regurgitation velocity and pulmonary artery acceleration time have important age- and phenotype-dependent limitations. Tricuspid annular plane systolic excursion (TAPSE), fractional area change, strain, ventricular geometry, and atrial indices have differing prognostic support, but direct validation of within-child change remains much more limited. Some treatment cohorts report improvement in right ventricular (RV) functional markers without commensurate changes in estimated pressure, while acute responsiveness does not necessarily predict long-term outcome. We synthesize these findings in a cross-domain table and a proposed stepwise approach that first checks measurement comparability, then reports domain-specific change, and finally integrates symptoms, WHO functional class, NT-proBNP, exercise capacity, and phenotype. The approach is a reporting aid, not a validated risk score or treatment algorithm. Research should prioritize repeat-acquisition reproducibility, the incremental prognostic value of serial change, and external validation.
Zitieren
APA
Diaconescu, C., Țarcă, E., Mîndru, D. E., Roșu, S. T., Tinică, G., Roșu, E. V., Sandrosean, A., Stănescu, R. Ș., & Luca, A. (2026). Serial Echocardiography in Pediatric Pulmonary Arterial Hypertension: A Narrative Review. Diagnostics, 16(22), 3802. https://doi.org/10.3390/diagnostics16223802
Vancouver
Diaconescu C, Țarcă E, Mîndru DE, Roșu ST, Tinică G, Roșu EV, et al. Serial Echocardiography in Pediatric Pulmonary Arterial Hypertension: A Narrative Review. Diagnostics. 2026;16(22):3802. doi:10.3390/diagnostics16223802
BibTeX
@article{Diaconescu2026,
author = {Diaconescu, Cosmin and Țarcă, Elena and Mîndru, Dana Elena and Roșu, Solange Tamara and Tinică, Grigore and Roșu, Eduard Vasile and Sandrosean, Argentina and Stănescu, Raluca Ștefania and Luca, Alina-Costina},
title = {Serial Echocardiography in Pediatric Pulmonary Arterial Hypertension: A Narrative Review},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {22},
pages = {3802},
doi = {10.3390/diagnostics16223802}
}
EUVIMED